One-pot synthesis, spectral characterization, biological evaluation, molecular docking studies and in silico ADME/Tox profiling of new 2,4,5 triaryl imidazole derivatives as anti tubercular agents
Indian Journal of Tuberculosis · 2023-10 · 70 (4) · 451-459
DOI: 10.1016/j.ijtb.2023.01.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Tuberculosis, 2023-10. Verfasst von Rama Krishna Munnaluri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Modeling and Medicinal Chemistry Group, Department of Chemistry, University College of Science, Osmania University, Hyderabad 500007, India. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Nitroimidazoles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, University Grants Commission, Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
BACKGROUND: Tuberculosis still looms large on the global epidemiological radar and warrants continuous effort in the direction of developing new anti TB drugs to battle evolving resistance mechanisms of the causative agent Mycobacterium tuberculosis. METHODS: In the present paper, synthesis of n has been attempted. All the synthesized compounds were characterized by 1H-NMR, 13C-NMR, IR and Mass spectroscopy. Anti TB profile of the synthesized compounds were tested by MABA assay employing M.tb H37Rv strain. RESULTS: Two compounds namely N-(2-acetoxy)-N-methyl-4-(4,5-diphenyl-1H-imidazole-2-yl) benzenamine and 2-(N-(4-(4,5-bis(4-methoxyphenyl)-1H-imidazole-2-yl)phenyl)-N-methylamino) ethanol exhibited impressive anti TB inhibitory potential with an MIC of 3.125 μg/mL. To visualize the binding interactions of the active compounds molecular docking studies were carried out on putative target M. tuberculosis Glutamine synthetase (MtGS) in complex with a trisubstituted imidazole. To ascertain their drug likeliness and safety profile in silico ADME/T prediction was performed on all the synthesized compounds. CONCLUSION: Three compounds 1a, 2g and 2c exhibited good inhibitory potency against M.tb H37Rv and all the synthesized compounds also show promising antifungal activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Modeling and Medicinal Chemistry Group, Department of Chemistry, University College of Science, Osmania University, Hyderabad 500007, India.
- Department of Chemistry, University College for Women, OU, Koti, Hyderabad, India.
- Molecular Modeling and Medicinal Chemistry Group, Department of Chemistry, University College of Science, Osmania University, Hyderabad 500007, India; Department of Chemistry, University College for Women, OU, Koti, Hyd…
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
- University Grants Commission
- Council of Scientific and Industrial Research, India
Zitieren
APA
Munnaluri, R. K., Chevula, J., Patnam, N., Yamini, L., & Manga, V. (2023). One-pot synthesis, spectral characterization, biological evaluation, molecular docking studies and in silico ADME/Tox profiling of new 2,4,5 triaryl imidazole derivatives as anti tubercular agents. Indian Journal of Tuberculosis, 70(4), 451-459. https://doi.org/10.1016/j.ijtb.2023.01.005
Vancouver
Munnaluri RK, Chevula J, Patnam N, Yamini L, Manga V. One-pot synthesis, spectral characterization, biological evaluation, molecular docking studies and in silico ADME/Tox profiling of new 2,4,5 triaryl imidazole derivatives as anti tubercular agents. Indian Journal of Tuberculosis. 2023;70(4):451-459. doi:10.1016/j.ijtb.2023.01.005
BibTeX
@article{Munnaluri2023,
author = {Munnaluri, Rama Krishna and Chevula, Janaiah and Patnam, Nagesh and Yamini, Lingala and Manga, Vijjulatha},
title = {One-pot synthesis, spectral characterization, biological evaluation, molecular docking studies and in silico ADME/Tox profiling of new 2,4,5 triaryl imidazole derivatives as anti tubercular agents},
journal = {Indian Journal of Tuberculosis},
year = {2023},
volume = {70},
number = {4},
pages = {451--459},
doi = {10.1016/j.ijtb.2023.01.005}
}
EUVIMED